Eslicarbazepine‐induced severe hyponatremia resulted in generalized tonic‐clonic seizure
Abstract Although eslicarbazepine is an anti‐seizure medication, it may result in seizure worsening if its use is complicated by severe hyponatremia, even long time after commencing this medication. The treatment is a replacement for another ASM.
Guardado en:
Autores principales: | Mhd Baraa Habib, Mohammad Elshafei, Elrazi Ali, Sundus Sardar, Khaled Ali, Naim Haddad, Mohamed Abdelaty |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/10e55b404f2849488349f5bcc8c51171 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures
por: Besag FM, et al.
Publicado: (2016) -
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
por: Sunkaraneni S, et al.
Publicado: (2017) -
A YOUNG MAN WITH GENERALIZED TONIC-CLONIC SEIZURES AND HYPOCALCAEMIA
por: Gulzar Ali, et al.
Publicado: (2019) -
Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
por: Tambucci R, et al.
Publicado: (2016) -
Asymptomatic hyponatremia precipitated by COVID-19 pneumonia
por: Abhinandan R. Chittal, et al.
Publicado: (2021)